Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » Lassa Virus Sequence Gives Insight into Viral Origins, Evolution

Lassa Virus Sequence Gives Insight into Viral Origins, Evolution

Aug 13, 2015
|
staff reporter

NEW YORK (GenomeWeb) – The Lassa virus, unlike its Ebola cousin, appears to have ancient origins and its appearances in humans seem to mostly be due to reservoir-to-human transmissions, according to an analysis of some 200 Lassa virus sequences.

"The reason Lassa hasn't yet grown into this huge epidemic is because there is limited transmission between humans," first author Kristian Andersen from the Scripps Research Institute said in a statement. "That's a major difference between Lassa virus and Ebola virus."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Oct
08
Featured Webinar

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

Sponsored by
Genecentric

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Infectious Disease

  1. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

  2. Mutations in Type I Interferon Immunity Genes Underlie Severe COVID-19

  3. ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

  4. Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

  5. Hologic Receives FDA Emergency Use Authorization for SARS-CoV-2 Testing of Asymptomatic Individuals

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.